The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military service members, veterans, and their families. The grant's objective is to conduct research on senescence-associated somatic mutations and their role in lung cancer etiology. The award period is from March 1, 2024 to February 28, 2025.
Generated 11/26/24, 4:13 AM